575 related articles for article (PubMed ID: 10673675)
21. Clinicopathologic understanding and control of varicella-zoster virus infection.
Asano Y
Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
[TBL] [Abstract][Full Text] [Related]
22. Varicella vaccination in children after bone marrow transplantation.
Sauerbrei A; Prager J; Hengst U; Zintl F; Wutzler P
Bone Marrow Transplant; 1997 Sep; 20(5):381-3. PubMed ID: 9339753
[TBL] [Abstract][Full Text] [Related]
23. Varicella Zoster Virus Infection in Children with Autologous Hematopoietic Cell Transplantation: A Retrospective, Single-Center Study in Korea.
Kang JM; Kim JM; Lee JW; Yoo KH; Sung KW; Koo HH; Kim YJ
Biol Blood Marrow Transplant; 2020 May; 26(5):965-971. PubMed ID: 31962166
[TBL] [Abstract][Full Text] [Related]
24. [Varicella-zoster virus infection after hematopoietic stem cell transplantation].
Akiyama H; Inoue T; Okoshi Y; Mori S; Ohashi K; Maeda Y; Sasaki T; Okuyama Y; Hiruma K; Sakamaki H
Rinsho Ketsueki; 2000 Jan; 41(1):20-4. PubMed ID: 10695394
[TBL] [Abstract][Full Text] [Related]
25. Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity.
Vermont CL; Jol-van der Zijde EC; Hissink Muller P; Ball LM; Bredius RG; Vossen AC; Lankester AC
Transpl Infect Dis; 2014 Apr; 16(2):188-94. PubMed ID: 24438482
[TBL] [Abstract][Full Text] [Related]
26. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
Balfour HH
Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
[TBL] [Abstract][Full Text] [Related]
27. Molecular and therapeutic aspects of varicella-zoster virus infection.
Quinlivan M; Breuer J
Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
[TBL] [Abstract][Full Text] [Related]
28. Prevention and treatment of VZV infections in patients with HIV.
Gershon AA
Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
[TBL] [Abstract][Full Text] [Related]
29. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.
Koc Y; Miller KB; Schenkein DP; Griffith J; Akhtar M; DesJardin J; Snydman DR
Biol Blood Marrow Transplant; 2000; 6(1):44-9. PubMed ID: 10707998
[TBL] [Abstract][Full Text] [Related]
30. [Infections caused by Varicella Zoster virus in children with cancer aged less than 15 years old].
Folatre I; Zolezzi P; Schmidt D; Marín F; Täger M
Rev Med Chil; 2003 Jul; 131(7):759-64. PubMed ID: 14513696
[TBL] [Abstract][Full Text] [Related]
31. Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation.
Vandenbosch K; Ovetchkine P; Champagne MA; Haddad E; Alexandrov L; Duval M
Biol Blood Marrow Transplant; 2008 Aug; 14(8):867-71. PubMed ID: 18640569
[TBL] [Abstract][Full Text] [Related]
32. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
Sauerbrei A; Wutzler P
J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
[TBL] [Abstract][Full Text] [Related]
33. Persistence and antiviral resistance of varicella zoster virus in hematological patients.
van der Beek MT; Vermont CL; Bredius RG; Marijt EW; van der Blij-de Brouwer CS; Kroes AC; Claas EC; Vossen AC
Clin Infect Dis; 2013 Feb; 56(3):335-43. PubMed ID: 23074321
[TBL] [Abstract][Full Text] [Related]
34. [Acyclovir therapy in varicella/zoster diseases in immunocompromised children with cancer].
Kuhn N; Landbeck G
Monatsschr Kinderheilkd; 1984 Feb; 132(2):105-9. PubMed ID: 6328285
[TBL] [Abstract][Full Text] [Related]
35. Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains high.
Blennow O; Fjaertoft G; Winiarski J; Ljungman P; Mattsson J; Remberger M
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1646-9. PubMed ID: 24914821
[TBL] [Abstract][Full Text] [Related]
36. Prevention of shingles by varicella zoster virus vaccination.
Holodniy M
Expert Rev Vaccines; 2006 Aug; 5(4):431-43. PubMed ID: 16989624
[TBL] [Abstract][Full Text] [Related]
37. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
38. Varicella zoster virus: review of its management.
Mustafa MB; Arduino PG; Porter SR
J Oral Pathol Med; 2009 Oct; 38(9):673-88. PubMed ID: 19691461
[TBL] [Abstract][Full Text] [Related]
39. Varicella zoster infection in renal transplant recipients: prevalence, complications and outcome.
Mustapic Z; Basic-Jukic N; Kes P; Lovcic V; Bubic-Filipi Lj; Mokos I; Kastelan Z; Zekan S
Kidney Blood Press Res; 2011; 34(6):382-6. PubMed ID: 21654179
[TBL] [Abstract][Full Text] [Related]
40. Incidence and clinical characteristics of herpes zoster after lung transplantation.
Manuel O; Kumar D; Singer LG; Cobos I; Humar A
J Heart Lung Transplant; 2008 Jan; 27(1):11-6. PubMed ID: 18187081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
